← All diseases
Cancer
Multiple myeloma
Do you want to receive a message when there is new research about Multiple myeloma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you receive a notification as soon as there is new research about Multiple myeloma. View what Premium costs.
Publications and studies (2183)
- Ixazomib-Lenalidomide-Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Hungarian Real-World Analysis. (2025/12/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Post-Transplant Double Malignancy: Multiple Myeloma and Papillary Renal Cell Carcinoma-A Case Report. (2025/12/30) ♡
- Emerging Real-World Treatment Patterns and Clinical Outcomes of Multiple Myeloma in Argentina and Brazil: Insights from the TOTEMM Study in the Private Healthcare Sector. (2025/12/29) ♡
- Microvesicles derived from bone marrow and peripheral blood can reflect tumor load in multiple myeloma. (2025/12/29) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Bilateral breast plasmacytomas in a male patient with relapsed multiple myeloma: A case report. (2025/12/26) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Precursor Dendritic Cell Proliferation in Multiple Myeloma: A Precursor to Acute Myeloid Leukemia. (2025/12/25) ♡
- Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States. (2025/12/24) ♡
- Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference. (2025/12/23) ♡
- First-in-Class Potent, Dual HDAC6/Proteasome Inhibitors Lacking a Hydroxamic Acid Motif: Discovery of Novel Anti-Multiple Myeloma Agents. (2025/12/22) ♡
- Minimally invasive augmented reality-guided lumbopelvic fixation for a large sacral plasmacytoma: illustrative case. (2025/12/22) ♡
- Extramedullary plasmacytoma of the tibial nerve: illustrative case. (2025/12/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Complications in a Patient With Multiple Myeloma Mimicking Bronchopneumonia. (2025/12/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A man in his 60s with immunodeficiency and hepatitis. (2025/12/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy and Safety of Newly Diagnosed Multiple Myeloma Combination Therapies: A Systematic Review Integrating Network Meta-Analysis and Real-World Vigilance Study. (2025/12/21) ♡
- Pleuro-Pulmonary Extramedullary Plasmacytomas in Multiple Myeloma: A 15-Year Experience from a Tertiary Center. (2025/12/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Suspected central nervous system involvement in multiple myeloma on MRI. (2025/12/20) ♡
- Elevated Allele Frequency and Male-Predominance of a Common LAG3 Germline Variant in Multiple Myeloma. (2025/12/20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of oral care models on the prevention of oral mucositis induced by high-doses of melphalan in patients undergoing ASCT. (2025/12/19) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Purulent Pericardial Abscess Caused by Escherichia coli in an Immunocompromised Patient Presenting With Mixed Septic and Cardiogenic Shock. (2025/12/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Addition of anti-CD38 mAb in newly diagnosed multiple myeloma: advancing toward quadruplet induction regimens. (2025/12/18) ♡
- Prognostic significance of hematological parameters and albumin in BCMA-targeted CAR-T therapy for multiple myeloma. (2025/12/17) ♡
- Alcohol consumption and risk of cancer: a Mendelian randomization analysis of four biobanks and consortium data. (2025/12/16) ♡
- Clinical outcomes of lenalidomide, bortezomib, and dexamethasone in multiple myeloma patients. (2025/12/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Intestinal Lymphangiectasia as a Rare Myeloma-Defining Event. (2025/12/14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Application of individualized low-protein diet nursing for managing multiple myeloma patients with renal impairment. (2025/12/12) ♡
- Successes and Challenges of Bispecific T-cell Engager Antibodies in the Treatment of Multiple Myeloma. (2025/12/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Extracellular vesicles in malignant and normal B lymphocyte growth and development. (2025/12/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Atypical Acute Encephalopathy Unmasking IgA Multiple Myeloma. (2025/12/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Myxedema Coma as the Initial Presentation of Undiagnosed Hypothyroidism: A Rare but Reversible Emergency. (2025/12/07) ♡
- Forty-year Development Alongside Juntendo University's Department of Hematology. (2025/12/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cast nephropathy in the ICU: Early recognition and extracorporeal strategies to improve outcomes. (2025/12/04) ♡
- Serum lipid levels and risk of lymphoid malignancies in the UK Biobank study. (2025/12/01) ♡
- Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis. (2025/12/01) ♡
- Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort. (2025/12/01) ♡
- Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology. (2025/12/01) ♡
- Incidence and Clinical Outcomes of Vitamin D Status and Myeloma Bone Disease Among Patients With Newly Diagnosed Multiple Myeloma (MM) in a Tropical Country-Retrospective Cohort Study. (2025/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Reshaping multiple myeloma treatment: recent breakthroughs. (2025/12/01) ♡
- [Analysis of Clinical Characteristics and Risk Factors for Bone Lesions in Patients with Multiple Myeloma]. (2025/12/01) ♡
- [Clinical Analysis of Ixazomib-Based Chemotherapy Regimens in the Treatment of Newly Diagnosed Multiple Myeloma with 1q21 Amplification]. (2025/12/01) ♡
- [Clinical Study of MiR-125b-5p/HIF-1α Pathway in Involvement of Vitamin D Deficiency in Pathogenesis of Multiple Myeloma]. (2025/12/01) ♡
- [Analysis of Risk Factors for Early Relapse/Progression in Patients with Multiple Myeloma and Development of a Nomogram Prediction Model]. (2025/12/01) ♡
- [Metabolic Characteristics of Multiple Myeloma Based on Non-Targeted Metabolomics]. (2025/12/01) ♡
- MiR-503-5p as a potential biomarker for deep venous thrombosis (DVT) in multiple myeloma (MM) and its role in disease development. (2025/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Extracellular vesicles in multiple myeloma-bone marrow niche crosstalk: from cellular dialogue to clinical perspectives. (2025/11/27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Diagnostic Potential of the Risk Factors Associated With Peripheral Neuropathy in Multiple Myeloma: Evidence From Logistic Regression Analysis. (2025/11/25) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide. (2025/11/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Challenging features of left ventricular wall thickening in a young patient with multiple myeloma and shock: when magnetic resonance imaging makes the difference-a case report. (2025/11/25) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Divergent Risks of Hematologic Malignancies Associated with GLP-1 Receptor Agonists and SGLT2 Inhibitors: Preliminary Findings from a Pilot Network Meta-Analysis. (2025/11/19) ♡
- Diverging global incidence trends of early-onset cancers: comparisons with incidence trends of later-onset cancers and mortality trends of early-onset cancers. (2025/11/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolomic Investigation of Myelodysplastic Syndromes, Multiple Myeloma, and Homozygous β-Thalassemia. (2025/11/14) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.